FMR LLC - TRANSPHORM INC ownership

TRANSPHORM INC's ticker is TGAN and the CUSIP is 89386L100. A total of 40 filers reported holding TRANSPHORM INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
FMR LLC ownership history of TRANSPHORM INC
ValueSharesWeighting
Q3 2023$3,503
-15.6%
1,578
+29.2%
0.00%
Q2 2023$4,151
-34.3%
1,221
-22.9%
0.00%
Q1 2023$6,320
+160.5%
1,584
+255.2%
0.00%
Q4 2022$2,426
-39.4%
446
-49.7%
0.00%
Q3 2022$4,000886
+1960.5%
0.00%
Q2 2022$0430.00%
Other shareholders
TRANSPHORM INC shareholders Q3 2023
NameSharesValueWeighting ↓
AIGH Capital Management LLC 4,619,558$10,255,4194.85%
Kohlberg Kravis Roberts & Co. L.P. 22,675,980$50,340,6761.77%
Worth Venture Partners, LLC 1,152,278$2,558,0571.52%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 250,084$555,1870.78%
Black Maple Capital Management LP 63,923$141,9090.10%
Taylor Frigon Capital Management LLC 62,500$138,7500.08%
Polar Asset Management Partners Inc. 1,009,702$2,241,5380.05%
Soros Fund Management 340,000$754,8000.01%
AMERIPRISE FINANCIAL INC 4,443,329$9,864,1910.00%
Stratos Wealth Partners, LTD. 25,640$56,9210.00%
View complete list of TRANSPHORM INC shareholders